Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
The EMBO Journal|March 19, 2005
Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressorSonia Rocha, Michelle D Garrett, Kirsteen J Campbell, et al.
Cancer Research|September 20, 2006
Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activationNayanta Sodha, Tine S Mantoni, Sean V Tavtigian, et al.
Chemical Science|November 27, 2024
Sequence-defined phosphoestamers for selective inhibition of the KRAS<sup>G12D</sup>/RAF1 interactionBini Claringbold, Steven Vance, Alexandra R Paul, et al.
Molecular Oncology|December 22, 2015
Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastomaJennifer R Smith, Lucas Moreno, Simon P Heaton, et al.
Current Opinion in Pharmacology|August 30, 2008
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promisesTimothy A Yap, Michelle D Garrett, Mike I Walton, et al.
FEBS Open Bio|June 26, 2025
Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell linesTharsagini V Nanthaprakash, Campbell W Gourlay, Ina Oehme, et al.
Cancer Research|March 13, 2020
CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer CellsRebecca F Rogers, Michael I Walton, Daniel L Cherry, et al.
Cell Cycle (Georgetown, Tex.)|December 14, 2007
The cyclin-dependent kinase inhibitor seliciclib (R-roscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosisSteven R Whittaker, Robert H Te Poele, Florence Chan, et al.
Pageof 8